Steve Elms, Director at ADMA BIOLOGICS, INC. (ADMA), sold 1,669,568 shares at $6.01 ($10.2M) on 2024-03-15, disclosed to the SEC on 2024-03-15.
Open-market sale of $10.2M ADMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.21 | 407,000 | $2.5M | 24.9% |
| 2 | $6.05 | 448,276 | $2.7M | 26.7% |
| 3 | $6.05 | 448,276 | $2.7M | 26.7% |
| 4 | $6.01 | 183,008 | $1.1M | 10.8% |
| 5 | $6.01 | 183,008 | $1.1M | 10.8% |
| Total | $6.08 avg | 1,669,568 |
| $10.2M |
| 100% |
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| MRKR | BUY | 2021-03-18 | $4.0M | — | Filing → |